These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16630171)

  • 21. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
    Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
    Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The paraoxonase gene polymorphism in stroke patients and lipid profile.
    Shin BS; Oh SY; Kim YS; Kim KW
    Acta Neurol Scand; 2008 Apr; 117(4):237-43. PubMed ID: 17854416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics. The elusive ALS genes.
    Garber K
    Science; 2008 Jan; 319(5859):20. PubMed ID: 18174402
    [No Abstract]   [Full Text] [Related]  

  • 25. Progranulin genetic variability contributes to amyotrophic lateral sclerosis.
    Sleegers K; Brouwers N; Maurer-Stroh S; van Es MA; Van Damme P; van Vught PW; van der Zee J; Serneels S; De Pooter T; Van den Broeck M; Cruts M; Schymkowitz J; De Jonghe P; Rousseau F; van den Berg LH; Robberecht W; Van Broeckhoven C
    Neurology; 2008 Jul; 71(4):253-9. PubMed ID: 18184915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.
    Cronin S; Greenway MJ; Prehn JH; Hardiman O
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):984-6. PubMed ID: 17702780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The paraoxonase disruption hypothesis in sporadic ALS steamrolled.
    Sand PG
    Neurol Sci; 2016 Jun; 37(6):1017-8. PubMed ID: 26886353
    [No Abstract]   [Full Text] [Related]  

  • 29. A link between ALS and short residence on Guam.
    Majoor-Krakauer D; Mulder PG; Rowland LP; Ottman R
    Neurology; 2005 May; 64(10):1819-20. PubMed ID: 15911829
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
    Fu R; Sun YM; Su Y; Wu Y; Luan Y
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):982-3. PubMed ID: 18430057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonase and coronary heart disease risk: language misleads, linkage misinforms, function clarifies.
    Loscalzo J
    Circ Cardiovasc Genet; 2008 Dec; 1(2):79-80. PubMed ID: 20031548
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.
    Stevens VL; Rodriguez C; Pavluck AL; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1226-8. PubMed ID: 16775186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival.
    Verde F; Tiloca C; Morelli C; Doretti A; Poletti B; Maderna L; Messina S; Gentilini D; Fogh I; Ratti A; Silani V; Ticozzi N
    Neurol Sci; 2019 Jul; 40(7):1469-1473. PubMed ID: 30903418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
    Regieli JJ; Jukema JW; Doevendans PA; Zwinderman AH; Kastelein JJ; Grobbee DE; van der Graaf Y
    J Am Coll Cardiol; 2009 Sep; 54(14):1238-45. PubMed ID: 19778663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.
    Wills AM; Cronin S; Slowik A; Kasperaviciute D; Van Es MA; Morahan JM; Valdmanis PN; Meininger V; Melki J; Shaw CE; Rouleau GA; Fisher EM; Shaw PJ; Morrison KE; Pamphlett R; Van den Berg LH; Figlewicz DA; Andersen PM; Al-Chalabi A; Hardiman O; Purcell S; Landers JE; Brown RH
    Neurology; 2009 Jul; 73(1):16-24. PubMed ID: 19321847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction.
    Morray B; Goldenberg I; Moss AJ; Zareba W; Ryan D; McNitt S; Eberly SW; Glazko G; Mathew J
    Am J Cardiol; 2007 Apr; 99(8):1100-5. PubMed ID: 17437735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between PON1 and population density in amyotrophic lateral sclerosis.
    Diekstra FP; Beleza-Meireles A; Leigh NP; Shaw CE; Al-Chalabi A
    Neuroreport; 2009 Jan; 20(2):186-90. PubMed ID: 19104460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.